GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Affluent Medical (XPAR:AFME) » Definitions » Total Stockholders Equity

Affluent Medical (XPAR:AFME) Total Stockholders Equity : €26.06 Mil (As of Jun. 2024)


View and export this data going back to 2021. Start your Free Trial

What is Affluent Medical Total Stockholders Equity?

Affluent Medical's Total Stockholders Equity for the quarter that ended in Jun. 2024 was €26.06 Mil. It refers to the net assets owned by shareholders. It does not include minority interest.

Total Stockholders Equity is used to calculate Book Value per Share. Affluent Medical's Book Value per Share for the quarter that ended in Jun. 2024 was €0.79. The ratio of a company's debt over equity can be used to measure how leveraged this company is. Affluent Medical's Debt-to-Equity for the quarter that ended in Jun. 2024 was 0.65.


Affluent Medical Total Stockholders Equity Historical Data

The historical data trend for Affluent Medical's Total Stockholders Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Affluent Medical Total Stockholders Equity Chart

Affluent Medical Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Total Stockholders Equity
Get a 7-Day Free Trial Premium Member Only 35.29 43.54 33.83 31.53 -

Affluent Medical Semi-Annual Data
Dec16 Dec17 Dec18 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Total Stockholders Equity Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 33.83 38.98 31.53 26.06 -

Affluent Medical  (XPAR:AFME) Total Stockholders Equity Explanation

1. Total Stockholders Equity is used to calculate Book Value per Share.

Affluent Medical's Book Value per Share for the quarter that ended in Jun. 2024 is

2. The ratio of a company's debt over equity can be used to measure how leveraged this company is.

Affluent Medical's Debt-to-Equity for the quarter that ended in Jun. 2024 is

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Affluent Medical Total Stockholders Equity Related Terms

Thank you for viewing the detailed overview of Affluent Medical's Total Stockholders Equity provided by GuruFocus.com. Please click on the following links to see related term pages.


Affluent Medical Business Description

Traded in Other Exchanges
Address
320, Avenue Archimede, Les Pleiades III, Batiment B, Aix-en-Provence, FRA, 13100
Affluent Medical is a medical device company. The company is developing, next-generation minimally invasive medical devices for the treatment of severe pathologies in urology and structural heart. The product portfolio of the company includes Artus, Kalios, Epygon, and Kardiozis. It has a single operating segment that conducts research and development of medical devices with a view to its future marketing.

Affluent Medical Headlines

No Headlines